Aspira Women's Health Inc. (AWHL): Depreciation & Amortization
$112.0K
Year ended 2025-12-31
$168.0K
Trailing 12 months to 2026-06-30
-24.9%
3-year compound annual growth
-15.8%
5-year compound annual growth
-9.1%
10-year compound annual growth
| Period ended | Depreciation & Amortization | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $112.0K | +21.7% | 2026-04-01, From 2025-01-01 |
| 2024-12-31 | $92.0K | -53.8% | 2026-04-01, From 2024-01-01 |
| 2023-12-31 | $199.0K | -24.6% | 2025-03-27, From 2023-01-01 |
| 2022-12-31 | $264.0K | -12.6% | 2024-04-01, From 2022-01-01 |
| 2021-12-31 | $302.0K | +14.0% | 2023-10-26, From 2021-01-01 |
| 2020-12-31 | $265.0K | -20.4% | 2022-03-31, From 2020-01-01 |
| 2019-12-31 | $333.0K | -50.7% | 2021-03-31, From 2019-01-01 |
| 2018-12-31 | $675.0K | -14.1% | 2020-04-07, From 2018-01-01 |
| 2017-12-31 | $786.0K | +8.7% | 2019-03-28, From 2017-01-01 |
| 2016-12-31 | $723.0K | +148.5% | 2018-03-13, From 2016-01-01 |
| 2015-12-31 | $291.0K | +106.4% | 2017-03-31, From 2015-01-01 |
| 2014-12-31 | $141.0K | +95.8% | 2016-03-30, From 2014-01-01 |
| 2013-12-31 | $72.0K | -16.3% | 2015-03-31, From 2013-01-01 |
| 2012-12-31 | $86.0K | +11.7% | 2014-03-31, From 2012-01-01 |
| 2011-12-31 | $77.0K | -32.5% | 2013-03-01, From 2011-01-01 |
| 2010-12-31 | $114.0K | n/a | 2012-03-27, From 2010-01-01 |
Depreciation & Amortization at similar companies
| Company | Year ended | Depreciation & Amortization | Change YoY |
|---|---|---|---|
| Aspira Women's Health Inc. (AWHL) | 2025-12-31 | $112.0K | +21.7% |
| Biomerica Inc (BMRA) | 2026-05-31 | $77.0K | -11.5% |
| Insight Molecular Diagnostics Inc. (IMDX) | 2025-12-31 | $2.19M | +48.4% |
| Immucell Corp (ICCC) | 2025-12-31 | $2.78M | +2.0% |
| Alpha Teknova, Inc. (TKNO) | 2025-12-31 | $6.34M | -3.6% |
| Volitionrx Ltd (VNRX) | 2025-12-31 | $983.7K | -11.6% |
| Celldex Therapeutics, Inc. (CLDX) | 2025-12-31 | $3.38M | +6.4% |
| Intellia Therapeutics, Inc. (NTLA) | 2025-12-31 | $9.77M | -5.0% |
| Myriad Genetics Inc (MYGN) | 2025-12-31 | $53.70M | -12.3% |
Compare AWHL, BMRA, IMDX, ICCC side by side · Screen every company in In Vitro & In Vivo Diagnostic Substances ↗